Your browser doesn't support javascript.
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Collier, Dami A; De Marco, Anna; Ferreira, Isabella A T M; Meng, Bo; Datir, Rawlings P; Walls, Alexandra C; Kemp, Steven A; Bassi, Jessica; Pinto, Dora; Silacci-Fregni, Chiara; Bianchi, Siro; Tortorici, M Alejandra; Bowen, John; Culap, Katja; Jaconi, Stefano; Cameroni, Elisabetta; Snell, Gyorgy; Pizzuto, Matteo S; Pellanda, Alessandra Franzetti; Garzoni, Christian; Riva, Agostino; Elmer, Anne; Kingston, Nathalie; Graves, Barbara; McCoy, Laura E; Smith, Kenneth G C; Bradley, John R; Temperton, Nigel; Ceron-Gutierrez, Lourdes; Barcenas-Morales, Gabriela; Harvey, William; Virgin, Herbert W; Lanzavecchia, Antonio; Piccoli, Luca; Doffinger, Rainer; Wills, Mark; Veesler, David; Corti, Davide; Gupta, Ravindra K.
  • Collier DA; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.
  • De Marco A; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Ferreira IATM; Division of Infection and Immunity, University College London, London, UK.
  • Meng B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.
  • Walls AC; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Kemp SA; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.
  • Bassi J; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Pinto D; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.
  • Silacci-Fregni C; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Bianchi S; Division of Infection and Immunity, University College London, London, UK.
  • Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Bowen J; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.
  • Culap K; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Jaconi S; Division of Infection and Immunity, University College London, London, UK.
  • Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Snell G; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Pellanda AF; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Garzoni C; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Riva A; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Elmer A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Kingston N; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Graves B; Vir Biotechnology, San Francisco, CA, USA.
  • McCoy LE; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Smith KGC; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
  • Bradley JR; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
  • Temperton N; Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy.
  • Barcenas-Morales G; NIHR Cambridge Clinical Research Facility, Cambridge, UK.
  • Harvey W; NIHR Bioresource, Cambridge, UK.
  • Virgin HW; Division of Infection and Immunity, University College London, London, UK.
  • Lanzavecchia A; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.
  • Piccoli L; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Doffinger R; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Wills M; NIHR Bioresource, Cambridge, UK.
  • Veesler D; University of Kent, Canturbury, UK.
  • Corti D; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
  • Gupta RK; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Nature ; 608(7922): E24, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-2069872
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Nature Year: 2022 Document Type: Article Affiliation country: S41586-022-05103-3

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Nature Year: 2022 Document Type: Article Affiliation country: S41586-022-05103-3